We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Bevacizumab Monotherapy in Treatment of Metastatic Melanoma

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00139360
First Posted: August 31, 2005
Last Update Posted: August 27, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Norwegian Cancer Society
Hoffmann-La Roche
Information provided by (Responsible Party):
Oddbjørn Straume, MD PhD, Haukeland University Hospital